Cancer device created at Rutgers to see if targeted chemotherapy is working

Rutgers researchers have created a device that can determine whether targeted chemotherapy drugs are working on individual cancer patients. The portable device, which uses artificial intelligence and biosensors, is up to 95.9% accurate in counting live cancer cells when they pass through electrodes, according to a study in the journal Microsystems & Nanoengineering.